HopeStage
Back to all studies
CompletedNCT05494437

PP-01 medicine study for cannabis withdrawal symptoms

About this titleRead the official source — NCT05494437
Medication studyAges 18–55United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 55 years.

Listed locations
Glendale and 17 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: October 27, 2022
Recruitment status
Completed
Enrollment listed in the registry
234
Sponsor
PleoPharma, Inc.
Sponsor type
Other organization
Study type
Drug
Intervention type
Combination product, Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT05494437
Official title
Show the full official title

A Phase 2, Multicenter, Randomized, Double-Blind, Multiple-Dose, Placebo Controlled Clinical Trial of Two Doses of PP-01 for the Mitigation of Cannabis Withdrawal Symptoms

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Glendale · Lemon Grove · Orange

15 more locations
  • Coral Springs
  • Fort Myers
  • Lauderhill
  • Decatur
  • Savannah
  • Chicago
  • Edgewood
  • Marrero
  • Shreveport
  • Berlin
  • Middleburg Heights
  • Oklahoma City
  • Charleston
  • Austin
  • Draper

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is PleoPharma, Inc.

Did this study involve medication?

Yes. The study involved medication, including Placebo, Nabilone and Gabapentin.

Who was this study for?

Listed age limits: 18 years to 55 years.

Want to explore more studies?

Explore studies